Related Experiment Videos
Some pharmacological properties of morphine-7,8-oxide (morphine epoxide)
Journal of Pharmacobio-Dynamics
|July 1, 1982
Abstract:
Morphine-7,8-oxide (morphine epoxide) is assumed to be a metabolite of morphine. Morphine epoxide in antinociceptive action was practically as potent as morphine. The development of tolerance in antinociceptive action was slower in the rats treated with morphine epoxide than in the rats with morphine. Furthermore, morphine epoxide was less potent than morphine in the inhibition of abstinence syndrome.
Insights
Morphine epoxide, a potential morphine metabolite, shows similar pain-relief effects but develops tolerance more slowly. It is less effective at inhibiting the morphine abstinence syndrome.
Area of Science:
- Pharmacology
- Neuroscience
- Drug Metabolism
Background:
- Morphine is a potent analgesic with significant side effects, including tolerance and withdrawal.
- Understanding morphine metabolites is crucial for developing safer and more effective pain management strategies.
Purpose of the Study:
- To investigate the antinociceptive effects and tolerance development of morphine-7,8-oxide (morphine epoxide) compared to morphine.
- To evaluate the efficacy of morphine epoxide in inhibiting the abstinence syndrome.
Main Methods:
- Comparative analysis of antinociceptive potency between morphine and morphine epoxide.
- Assessment of tolerance development rates in animal models treated with morphine or morphine epoxide.
- Evaluation of the compounds' effects on the inhibition of abstinence syndrome.
Main Results:
- Morphine epoxide demonstrated antinociceptive potency comparable to morphine.
- Slower development of antinociceptive tolerance was observed in rats treated with morphine epoxide compared to morphine.
- Morphine epoxide was less potent than morphine in inhibiting the abstinence syndrome.
Conclusions:
- Morphine epoxide is a potent antinociceptive agent with a potentially more favorable tolerance profile than morphine.
- Morphine epoxide may have a limited role in mitigating morphine withdrawal symptoms.